JP Patent

JP2022140559A — Ｒａｄ１９０１－２ｈｃｌの多形性形態

Assigned to Radius Pharmaceuticals Inc · Expires 2022-09-26 · 4y expired

What this patent protects

【課題】ＲＡＤ１９０１－２ＨＣＬの多形性形態を提供すること。【解決手段】RAD1901-2HClの結晶形態。【選択図】なし

USPTO Abstract

【課題】ＲＡＤ１９０１－２ＨＣＬの多形性形態を提供すること。【解決手段】RAD1901-2HClの結晶形態。【選択図】なし

Drugs covered by this patent

elacestrant-hydrochloride (ELACESTRANT HYDROCHLORIDE)

Patent Metadata

Patent number: JP2022140559A
Jurisdiction: JP
Classification: —
Expires: 2022-09-26
Drug substance claim: No
Drug product claim: No
Assignee: Radius Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.